A Phase 2/3 Randomized, Openn-Label, Multi-center Study to Determine the Safety and Efficacy of Solithromycin in Adolescents (12 to17 years of age, inclusive) and Children (>- 2 months to < 12 years of age) with Suspected or Confirmed Community
Clinical Trial Grant
Administered By
Pediatrics, Critical Care Medicine
Awarded By
Duke Clinical Research Institute
Start Date
May 22, 2017
End Date
May 23, 2018
Administered By
Pediatrics, Critical Care Medicine
Awarded By
Duke Clinical Research Institute
Start Date
May 22, 2017
End Date
May 23, 2018